Calibrated Breast Density Measurements.


Journal

Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159

Informations de publication

Date de publication:
09 2019
Historique:
received: 07 06 2018
revised: 28 09 2018
accepted: 04 10 2018
pubmed: 14 12 2018
medline: 14 5 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

Mammographic density is an important risk factor for breast cancer, but translation to the clinic requires assurance that prior work based on mammography is applicable to current technologies. The purpose of this work is to evaluate whether a calibration methodology developed previously produces breast density metrics predictive of breast cancer risk when applied to a case-control study. A matched case control study (n = 319 pairs) was used to evaluate two calibrated measures of breast density. Two-dimensional mammograms were acquired from six Hologic mammography units: three conventional Selenia two-dimensional full-field digital mammography systems and three Dimensions digital breast tomosynthesis systems. We evaluated the capability of two calibrated breast density measures to quantify breast cancer risk: the mean (PG In adjusted models, both PG The calibrated PG

Identifiants

pubmed: 30545682
pii: S1076-6332(18)30473-2
doi: 10.1016/j.acra.2018.10.009
pmc: PMC6557684
mid: NIHMS1512791
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1181-1190

Subventions

Organisme : NCI NIH HHS
ID : U01 CA200464
Pays : United States

Informations de copyright

Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Références

Med Phys. 2002 Aug;29(8):1867-80
pubmed: 12201434
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
Med Phys. 2006 Nov;33(11):4350-66
pubmed: 17153414
Biomed Eng Online. 2008 Mar 28;7:13
pubmed: 18373863
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1074-81
pubmed: 18483328
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):837-45
pubmed: 19258482
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1754-62
pubmed: 19505909
Med Phys. 2009 Dec;36(12):5380-90
pubmed: 20095250
Biomed Eng Online. 2010 Nov 16;9:73
pubmed: 21080916
Acad Radiol. 2011 May;18(5):547-55
pubmed: 21371912
Acad Radiol. 2011 May;18(5):556-64
pubmed: 21474058
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1473-82
pubmed: 21610220
Ann Intern Med. 2011 Jul 5;155(1):10-20
pubmed: 21727289
Acad Radiol. 2011 Nov;18(11):1430-6
pubmed: 21971260
Breast Cancer Res. 2011;13(6):223
pubmed: 22114898
Breast Cancer Res. 2013 Jan 04;15(1):R1
pubmed: 23289950
Biomed Eng Online. 2013 Nov 09;12:114
pubmed: 24207013
Breast Cancer Res. 2013 Oct 01;15(5):R92
pubmed: 24286369
Med Phys. 2013 Nov;40(11):113502
pubmed: 24320473
Breast Cancer Res Treat. 2014 Apr;144(3):479-502
pubmed: 24615497
J Natl Cancer Inst. 2014 May 10;106(5):null
pubmed: 24816206
Cancer. 2014 Oct 1;120(19):2955-64
pubmed: 24830599
Med Phys. 2015 Feb;42(2):623-36
pubmed: 25652480
Breast Cancer Res. 2015 Jul 09;17:84
pubmed: 26155950
Transl Oncol. 2015 Dec;8(6):435-45
pubmed: 26692524
Radiology. 2016 Jun;279(3):710-9
pubmed: 26694052
Ann Intern Med. 2016 Feb 16;164(4):268-78
pubmed: 26757021
Breast Cancer Res. 2016 Sep 20;18(1):91
pubmed: 27645219
Diagnostics (Basel). 2017 May 31;7(2):
pubmed: 28561776
Breast Cancer Manag. 2015;4(4):209-221
pubmed: 28943893
Breast Cancer Res. 2018 Feb 05;20(1):10
pubmed: 29402289
J Natl Cancer Inst. 2018 Sep 1;110(9):994-1002
pubmed: 29490057
Med Phys. 2019 Feb;46(2):679-688
pubmed: 30525207
Eur J Radiol. 1997 Feb;24(2):131-6
pubmed: 9097055

Auteurs

Erin E Fowler (EE)

Cancer Epidemiology Department, Moffitt Cancer Center & Research Institute, 12902 Bruce B Downs Blvd, Mail Stop: MRC Can/Cont, Tampa, FL 33612.

Autumn Smallwood (A)

Corporate Compliance Department, Moffitt Cancer Center & Research Institute, 12902 Bruce B Downs Blvd, Tampa, FL 33612.

Nadia Khan (N)

No Affiliation.

Cassandra Miltich (C)

Cancer Epidemiology Department, Moffitt Cancer Center & Research Institute, 12902 Bruce B Downs Blvd, Mail Stop: MRC Can/Cont, Tampa, FL 33612.

Thomas A Sellers (TA)

Cancer Epidemiology Department, Moffitt Cancer Center & Research Institute, 12902 Bruce B Downs Blvd, Mail Stop: MRC Can/Cont, Tampa, FL 33612.

John Heine (J)

Cancer Epidemiology Department, Moffitt Cancer Center & Research Institute, 12902 Bruce B Downs Blvd, Mail Stop: MRC Can/Cont, Tampa, FL 33612. Electronic address: john.heine@moffitt.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH